Giampiero De Luca

Title: Giampiero De Luca: Innovator in Pharmaceutical Science

Introduction

Giampiero De Luca is a notable inventor based in Conches, Geneva, Switzerland. He has made significant contributions to the field of pharmaceutical science, particularly in the treatment of multiple sclerosis. With a total of 4 patents to his name, De Luca's work has the potential to impact many lives.

Latest Patents

One of his latest patents is focused on a Cladribine regimen for treating multiple sclerosis. This invention relates to the use of Cladribine for the preparation of a pharmaceutical formulation aimed at treating multiple sclerosis, especially relapsing-remitting multiple sclerosis or early secondary progressive multiple sclerosis. The formulation is designed for oral administration, allowing for possible re-treatments. Another significant patent involves a method of producing functional protein domains. This invention provides a method for creating fragments of primary translational products that consist of one or more distinct protein domains encoded by specific subsets of exonic sequences. The method is based on integrating a regulatory unit into the eukaryotic gene coding for the primary translational product through a single homologous recombination event.

Career Highlights

Giampiero De Luca is currently employed at Merck Serono S.A., a leading company in the biopharmaceutical sector. His work at Merck Serono has allowed him to focus on innovative solutions in drug development and therapeutic applications.

Collaborations

Throughout his career, De Luca has collaborated with notable colleagues such as Arnaud Ythier and Alain Munafo. These collaborations have further enriched his research and development efforts.

Conclusion

Giampiero De Luca stands out as an influential inventor in the pharmaceutical industry, with a focus on innovative treatments for multiple sclerosis. His contributions through patents and collaborations continue to shape the future of medical science.